Press releases and news

2021-05-11 14:25 Regulatory
The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 11 May 2021 by postal voting whereby the shareholders primarily resolved on the following matters. Annual report and resultsThe annual general...

2021-05-06 08:45 Regulatory Interim
Press release: Uppsala, May 6, 2021. Senzime AB’s (publ) Interim Report for January-March 2021 is now available on the company’s website www.senzime.com. Financial information January – March Despite the fact that Covid-19 continued...

2021-04-20 08:51
To take advantage of the opportunities the need for adequate anesthesia monitoring entails, Senzime is now expanding its commercial capacity in the US market through further recruitment of its own sales staff and by entering into distribution agreement...

2021-04-19 08:54 Regulatory Annual
For further information, please contact: Pia Renaudin, CEO of Senzime AB Tel: +46 (0)70-813 34 17, email: pia.renaudin@senzime.com Erik Bergman, CFO Tel: +46 (0)73-258 81 59, e-post: erik.bergman@senzime.com TO THE EDITORS About Senzime Senzime develops...

2021-04-12 11:54 Regulatory
Notice etc. Shareholders who wish to participate at the annual general meeting must: register with the Company no later than Monday 10 May 2021 by submitting a postal voting form in accordance with the instructions below to be received by the Company...

2021-03-10 09:05
As stated in the article, “Comparison of the TetraGraph and the TOFscan for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit”[1], the lead author, Dr. J. Ross Renew reports that the number of patients arriving...

2021-03-05 15:28 Regulatory
Election of new member of the Board of Directors The extra general meeting resolved to elect Eva Walde as new member of the Board of Directors. For further information, please contact: Pia Renaudin, CEO of Senzime AB Tel: +46 708-13 34 17, e-mail: pia.renaudin@senzime.com...

2021-03-04 14:27
There are more than 3,000 hospitals in South Korea and more than 700 000 operations are performed annually where anesthesia and muscle relaxants are used. “This is a huge leap for patient safety and an acknowledgement of the need to monitor patients...

2021-02-26 08:45 Regulatory Interim
Financial information for the fourth quarter 2020 Financial information for January-December 2020 “Our vision is a world where patients wake up safely after surgery. For this purpose, we have developed a medical device - TetraGraph® - with associated...

2021-02-19 08:58 Regulatory
Right to attend the extra general meeting Due to the corona pandemic and in order to ensure the health and safety of shareholders, employees and other stakeholders, the board of directors in Senzime has resolved that the shareholders in Senzime may not...